Lifeboat Foundation

More magnesium in our daily diet leads to better brain health as we age, according to scientists from the Neuroimaging and Brain Lab at The Australian National University (ANU).

The researchers say increased intake of magnesium-rich foods such as spinach and nuts could also help reduce the risk of dementia, which is the second leading cause of death in Australia and the seventh biggest killer globally.

The study of more than 6,000 cognitively healthy participants in the United Kingdom aged 40 to 73 found people who consume more than 550 milligrams of magnesium each day have a brain age that is approximately one year younger by the time they reach 55 compared with someone with a normal magnesium intake of about 350 milligrams a day.

Having both diabetes and tooth loss contributes to worse cognitive function and faster cognitive decline in older adults, according to a new study published in a special issue of the Journal of Dental Research focused on aging and oral health.

“Our findings underscore the importance of dental care and diabetes management for older adults in reducing the devastating personal and societal costs of Alzheimer’s disease and other related dementias,” said Bei Wu, vice dean for research at NYU Rory Meyers College of Nursing and co-director of the NYU Aging Incubator, as well as the study’s lead author.

Diabetes is a known risk factor for cognitive decline and dementia. Several of the hallmarks of diabetes —high blood sugar, insulin resistance, inflammation, and related heart disease—are thought to contribute to changes in the brain.

When people suffer spinal cord injuries and lose mobility in their limbs, it’s a neural signal processing problem. The brain can still send clear electrical impulses and the limbs can still receive them, but the signal gets lost in the damaged spinal cord.

The Center for Sensorimotor Neural Engineering (CSNE)—a collaboration of San Diego State University with the University of Washington (UW) and the Massachusetts Institute of Technology (MIT)—is working on an implantable brain chip that can record neural electrical signals and transmit them to receivers in the limb, bypassing the damage and restoring movement. Recently, these researchers described in a study published in the journal Nature Scientific Reports a critical improvement to the technology that could make it more durable, last longer in the body and transmit clearer, stronger signals.

The technology, known as a brain-computer interface, records and transmits signals through electrodes, which are tiny pieces of material that read signals from brain chemicals known as neurotransmitters. By recording brain signals at the moment a person intends to make some movement, the interface learns the relevant electrical signal pattern and can transmit that pattern to the limb’s nerves, or even to a prosthetic limb, restoring mobility and motor function.

A team from Korea created more flexible neural electrodes that minimize tissue damage and still transmit clear brain signals.

Electrodes placed in the brain record neural activity, and can help treat neural diseases like Parkinson’s and epilepsy. Interest is also growing in developing better brain-machine interfaces, in which electrodes can help control prosthetic limbs. Progress in these fields is hindered by limitations in electrodes, which are relatively stiff and can damage soft brain tissue.

Designing smaller, gentler electrodes that still pick up brain signals is a challenge because brain signals are so weak. Typically, the smaller the electrode, the harder it is to detect a signal. However, a team from the Daegu Gyeongbuk Institute of Science & Technology in Korea developed new probes that are small, flexible and read brain signals clearly.

Induced pluripotent stem cells offer great therapeutic potential and are a valuable tool for understanding how different diseases develop. New research shows that such stem cell lines should be regularly screened for genetic mutations to ensure the accuracy of the disease models.

In the past 10 years, scientists have learned to create induced pluripotent stem cells (iPSC) from ordinary cells by genetic reprogramming. These cells are widely used to study diseases, as they can be differentiated to almost any cell type of the body, and they can be generated from any individual. However, a key remaining methodological challenge is that the differentiation process is subject to major technical variation for mostly unknown reasons.

HiLIFE Tenure Track Professor Helena Kilpinen and her group at the University of Helsinki use stem cells for studying the biological mechanisms of neurodevelopmental and other brain-related diseases.

Plants use photosynthesis to harvest energy from sunlight. Now researchers at the Technical University of Munich (TUM) have applied this principle as the basis for developing new sustainable processes which in the future may produce syngas (synthetic gas) for the large-scale chemical industry and be able to charge batteries.

Syngas, a mixture of carbon monoxide and hydrogen, is an important intermediate product in the manufacture of many chemical starter materials such as ammonia, methanol and synthetic hydrocarbon fuels. “Syngas is currently made almost exclusively using fossil raw materials,” says Prof. Roland Fischer from the Chair of Inorganic and Organometallic Chemistry.

A yellow powder, developed by a research team led by Fischer, is to change all that. The scientists were inspired by photosynthesis, the process plants use to produce chemical energy from light. “Nature needs carbon dioxide and water for photosynthesis,” says Fischer. The nanomaterial developed by the researchers imitates the properties of the enzymes involved in photosynthesis. The “nanozyme” produces syngas using carbon dioxide, water and light in a similar manner.

Scientists at the University of Groningen used a silver sawtooth nanoslit array to produce valley-coherent photoluminescence in two-dimensional tungsten disulfide flakes at room temperature. Until now, this could only be achieved at very low temperatures. Coherent light can be used to store or transfer information in quantum electronics. This plasmon-exciton hybrid device is promising for use in integrated nanophotonics (light-based electronics). The results were published in Nature Communications on 5 February.

Tungsten disulfide has interesting electronic properties and is available as a 2-D material. “The electronic structure of monolayer tungsten disulfide shows two sets of lowest energy points or valleys,” explains Associate Professor Justin Ye, head of the Device Physics of Complex Materials group at the University of Groningen. One possible application is in photonics, as it can emit light with valley-dependent circular polarization—a new degree of freedom to manipulate information. However, valleytronics requires coherent and polarized light. Unfortunately, previous work showed that photoluminescence polarization in tungsten disulfide is almost random at room temperature.

A team of chemists, engineers, material scientists and physicists from Princeton University, Rutgers University and the University of Regensburg has developed a chemical exfoliation technique to produce single-molecule-thick tungsten disulfide ink. The group describes their technique in a paper published in the journal Science Advances.

As research continues into the creation of truly useful quantum computers, scientists continue to search for new materials that could support such machines. In this new effort, the research team looked into finding ways to print very cold circuits inside quantum computers using superconducting ink.

The new method involved a material consisting of layers of tungsten disulfide and potassium. The researchers exfoliated the material by dunking it into a sulfuric acid solution. This dissolved the potassium and left behind single-molecule layers of tungsten disulfide. The final step involved rinsing the acid and remnants in it, leaving the layers of tungsten suspended in a tub of water. In this state, the researchers found that the layers of tungsten disulfide could be used as a form of ink that could be printed onto various types of surfaces, such as plastic, silicon or glass. This left a one-molecule-thick coating on the material.

Corneal transplants can be the last step to returning clear vision to many patients suffering from eye disease. Each year, approximately 80,000 corneal transplantations take place in the U.S. Worldwide, more than 184,000 corneal transplantation surgeries are performed annually.

However, rejection rates for the corneal grafts can be as high as 10%. This is largely due to poor patient compliance to the medications, which require frequent administrations of topical eyedrops over a long period of time.

This becomes especially acute when patients show signs of early rejection of the transplanted corneas. When this occurs, patients need to apply topical eyedrops hourly to rescue the corneal grafts from failure.